🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationNeedle gauge and dead space — minimizing waste in compounded vials

Needle gauge and dead space — minimizing waste in compounded vials

JennaRN Thu, May 21, 2026 at 4:36 AM 5 replies 413 viewsPage 1 of 1
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
May 21, 2026 at 4:36 AM#1

A reference post rather than a discussion. Corrections are the point; I would rather this be right than mine. It is about the dosing arithmetic, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Dead space is the answer to the missing dose. A fixed-needle insulin syringe holds a few microlitres in the hub and needle after the plunger bottoms out, and on small draws that is a measurable percentage of every dose. Across ten draws it adds up to most of an eleventh, which is exactly the "nine draws from a ten-dose vial" complaint. Luer-lock syringes are worse; low-dead-space fixed-needle designs are better.

The condition it depends on

It is worth saying that rounding to the nearest whole unit is usually acceptable at maintenance doses and is not acceptable at the bottom of a ladder, where one unit can be a fifth of the intended dose.

The practical version

The three numbers to write on the vial: total mg, total ml, and mg per ml. Everything else is division. And the sanity check is that dose volume times number of doses should be less than the volume you put in, because dead space takes the difference.

What I am not sure about

The question I want answered is how to check the arithmetic without trusting a website calculator, since three calculators gave me three answers. Numbers rather than impressions, if you have them.

— JennaRN · corrections welcome and will be edited into this post with credit
10 5Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 7 others
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
May 21, 2026 at 4:44 AM#2
JennaRN said:
Dead space is the answer to the missing dose.

JennaRN has the substance of this right. The condition it depends on is worth stating. Do it in two steps and it stops being confusing. First concentration: 10mg into 2ml is 5mg/ml. Then volume: a 0.5mg dose is 0.5 ÷ 5 = 0.1ml. Then units, and this is where people go wrong — a U-100 syringe is graduated in hundredths of a millilitre, so 0.1ml is 10 units. The word "units" has nothing to do with milligrams; it is a volume marking that exists because insulin happens to come at 100 units per ml.

9 4PharmacoVig_BOS, SurmountFan_IN, PeptideChemSF and 6 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
May 21, 2026 at 4:52 AM#3
JennaRN said:
Dead space is the answer to the missing dose.

I am going to disagree with reconstituting low as a general rule. More diluent, more punctures, more in-use days at room temperature, and the stability trade-off is real. Precision is not the only variable being optimised.

8 3mark_tokyo, hans_munich, jason_sac26 and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
May 21, 2026 at 5:00 AM#4

Short answer first, then the reasoning. Concentration choice is a precision decision, not a preference. Reconstitute high and every dose is a tiny volume where one unit of syringe error is a large fraction of the dose. Reconstitute low and you get more graduations per dose, so the same hand tremor costs proportionally less. Against that, more diluent means more benzyl alcohol and a shorter comfortable in-use window.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

7 2FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 4 others
Reply Quote Save Share Report
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
May 21, 2026 at 5:42 AM#5
Dr.ObesityMed said:
Do it in two steps and it stops being confusing.

Same position here, arrived at the long way round. Worth adding the genuine exception, because it is real and narrow: a change made for an identified patient where the prescriber determines it produces a significant clinical difference for that patient. A grid of fixed doses offered to everybody is not that, whatever the intake form says.

6 1mike_mealprep, NicoleRaleigh, james_edin and 3 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register